Senti Biosciences Holdings, Inc.: adjourns 2026 annual meeting

What happened Senti Biosciences Holdings, Inc. announced on Oct 8, 2026 that it convened its virtual 2026 annual meeting of stockholders and adjourned the meeting without conducting any business to have further time to solicit votes in favor of the Merger Agreement Proposal. The company said a quorum was present. The meeting will be reconvened on Oct 15, 2026 at 8:00 a.m., Pacific time, virtually via the Internet at www.virtualshareholdermeeting.com/SNTI2026.

Key details

• The company filed the definitive proxy statement on Schedule 14A on Sep 24, 2026.
• The record date for the annual meeting remains Sep 23, 2026.
• The filing states no changes were made to the proposals and that all polls will remain open.
• The Current Report on Form 8-K may be deemed solicitation material; the company and its directors and executive officers may be participants in the solicitation.

Why it may matter This report was filed as Item 8.01 (other events) and covers the adjournment and planned reconvening of the Oct 8, 2026 annual meeting and related solicitation of proxies for the Merger Agreement Proposal. This filing does not show why the company acted.